Skip to main content
Fig. 3 | Malaria Journal

Fig. 3

From: Drug resistance markers within an evolving efficacy of anti-malarial drugs in Cameroon: a systematic review and meta-analysis (1998–2020)

Fig. 3Fig. 3

a Subgroup analysis for pooled prevalence of Pfcrt K76T mutation from 1998 to 2020. b Subgroup analysis for pooled prevalence of Pfcrt CVIET haplotype mutations from 1998–2020. c Subgroup analysis for pooled prevalence of Pfmdr1 N86Y haplotype mutations from 1998 to 2020. d Subgroup analysis for pooled prevalence of Pfdhfr IRN haplotype mutations from 1998 to 2020. e Subgroup analysis for pooled prevalence of Pfdhfr-Pfdhps IRNG haplotype mutations from 1998 to 2020. f Subgroup analysis for pooled prevalence of Pfk13 mutations from 1998 to 2020

Back to article page

Malaria Journal

ISSN: 1475-2875

Contact us